Atossa Genetics Stock Profit Margin
ATOS Stock | USD 1.28 0.01 0.78% |
Atossa Genetics fundamentals help investors to digest information that contributes to Atossa Genetics' financial success or failures. It also enables traders to predict the movement of Atossa Stock. The fundamental analysis module provides a way to measure Atossa Genetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atossa Genetics stock.
Last Reported | Projected for Next Year | ||
Net Loss | -10.3 K | -9.8 K |
Atossa | Profit Margin |
Atossa Genetics Company Profit Margin Analysis
Atossa Genetics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Atossa Genetics Profit Margin | (9.8K) |
Most of Atossa Genetics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atossa Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Atossa Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Atossa Genetics is extremely important. It helps to project a fair market value of Atossa Stock properly, considering its historical fundamentals such as Profit Margin. Since Atossa Genetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Atossa Genetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Atossa Genetics' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Atossa Pretax Profit Margin
Pretax Profit Margin |
|
Atossa Genetics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Atossa Genetics from analyzing Atossa Genetics' financial statements. These drivers represent accounts that assess Atossa Genetics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Atossa Genetics' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 3.0M | 4.2M | 13.3M | 10.7M | 12.4M | 16.6M | |
Enterprise Value | (4.2M) | (6.1M) | 809.6K | (28.8M) | (33.1M) | (31.5M) |
Atossa Fundamentals
Return On Equity | -0.31 | ||||
Return On Asset | -0.2 | ||||
Current Valuation | 86.26 M | ||||
Shares Outstanding | 125.8 M | ||||
Shares Owned By Insiders | 0.05 % | ||||
Shares Owned By Institutions | 28.20 % | ||||
Number Of Shares Shorted | 12.45 M | ||||
Price To Earning | (0.62) X | ||||
Price To Book | 2.19 X | ||||
EBITDA | (31.35 M) | ||||
Net Income | (30.09 M) | ||||
Cash And Equivalents | 125.54 M | ||||
Cash Per Share | 0.99 X | ||||
Total Debt | 5.24 M | ||||
Current Ratio | 35.19 X | ||||
Book Value Per Share | 0.59 X | ||||
Cash Flow From Operations | (20.94 M) | ||||
Short Ratio | 20.27 X | ||||
Earnings Per Share | (0.21) X | ||||
Target Price | 5.83 | ||||
Number Of Employees | 12 | ||||
Beta | 1.23 | ||||
Market Capitalization | 161.03 M | ||||
Total Asset | 96.25 M | ||||
Retained Earnings | (186.29 M) | ||||
Working Capital | 112.63 M | ||||
Current Asset | 4.29 M | ||||
Current Liabilities | 2.5 M | ||||
Net Asset | 96.25 M |
About Atossa Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atossa Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atossa Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atossa Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.